BackCodiak Biosciences Overview

Codiak Biosciences Research & Development

Research & Development expenses for CDAK.

Quarterly R&D Expenses

$10.85M
↓ 29.87% YoY

As of Sep 30, 2022

Annual R&D Expenses (TTM)

$70.73M
↑ 16.4% YoY

Trailing 12 months ending Sep 30, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin